{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:56:27Z","timestamp":1788555387127,"version":"build-2803163510"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,5,25]],"date-time":"2016-05-25T00:00:00Z","timestamp":1464134400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s11739-016-1466-y","type":"journal-article","created":{"date-parts":[[2016,5,25]],"date-time":"2016-05-25T06:29:54Z","timestamp":1464157794000},"page":"781-791","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Systemic and organ involvement in monogenic autoinflammatory disorders: a global review filtered through internists\u2019 lens"],"prefix":"10.1007","volume":"11","author":[{"given":"Marco","family":"Cattalini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Soliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Lopalco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donato","family":"Rigante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Cantarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,25]]},"reference":[{"key":"1466_CR1","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.25.022106.141627","volume":"27","author":"SL Masters","year":"2009","unstructured":"Masters SL, Simon A, Aksentijevich I, Kastner DL (2009) Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu Rev Immunol 27:621\u2013668","journal-title":"Annu Rev Immunol"},{"key":"1466_CR2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10067-014-2721-0","volume":"34","author":"L Cantarini","year":"2015","unstructured":"Cantarini L, Vitale A, Lucherini OM, De Clemente C, Caso F, Costa L et al (2015) The labyrinth of autoinflammatory disorders: a snapshot on the activity of a third-level center in Italy. Clin Rheumatol 34:17\u201328","journal-title":"Clin Rheumatol"},{"key":"1466_CR3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4081\/reumatismo.2013.55","volume":"65","author":"L Cantarini","year":"2013","unstructured":"Cantarini L, Vitale A, Lucherini OM, Muscari I, Magnotti F, Brizi G et al (2013) Childhood versus adulthood-onset autoinflammatory disorders: myths and truths intertwined. Reumatismo 65:55\u201362","journal-title":"Reumatismo"},{"key":"1466_CR4","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/ard.2006.052688","volume":"65","author":"S Ozen","year":"2006","unstructured":"Ozen S, Hoffman HM, Frenkel J, Kastner D (2006) Familial Mediterranean fever (FMF) and beyond: a new horizon. Ann Rheum Dis 65:961\u2013964","journal-title":"Ann Rheum Dis"},{"key":"1466_CR5","first-page":"163","volume":"10","author":"D Rigante","year":"2006","unstructured":"Rigante D, La Torraca I, Ansuini V, Compagnone A, Sall\u00ec A, Stabile A (2006) The multi-face expression of familial Mediterranean fever in the child. Eur Rev Med Pharmacol Sci 10:163\u2013171","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1466_CR6","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(97)09408-7","volume":"351","author":"E Ben-Chetrit","year":"1998","unstructured":"Ben-Chetrit E, Levy M (1998) Familial Mediterranean fever. Lancet 351:659\u2013664","journal-title":"Lancet"},{"key":"1466_CR7","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/annrheumdis-2012-202580","volume":"73","author":"M Stoffels","year":"2013","unstructured":"Stoffels M, Szperl A, Simon A, Netea MG, Plantinga TS, van Deuren M et al (2013) MEFV mutations affecting pyrin amino acid 577 cause autosomal dominant autoinflammatory disease. Ann Rheum Dis 73:455\u2013461","journal-title":"Ann Rheum Dis"},{"key":"1466_CR8","doi-asserted-by":"crossref","first-page":"39320","DOI":"10.1074\/jbc.M104730200","volume":"276","author":"N Richards","year":"2001","unstructured":"Richards N, Schaner P, Diaz A, Stuckey J, Shelden E, Wadhwa A et al (2001) Interaction between pyrin and the apoptotic speck protein (ASC) modulates ASC-induced apoptosis. J Biol Chem 276:39320\u201339329","journal-title":"J Biol Chem"},{"key":"1466_CR9","first-page":"1","volume":"14","author":"D Rigante","year":"2010","unstructured":"Rigante D (2010) The protean visage of systemic autoinflammatory syndromes: a challenge for inter-professional collaboration. Eur Rev Med Pharmacol Sci 14:1\u201318","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1466_CR10","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.autrev.2014.08.001","volume":"13","author":"D Rigante","year":"2014","unstructured":"Rigante D, Vitale A, Lucherini OM, Cantarini L (2014) The hereditary autoinflammatory disorders uncovered. Autoimmun Rev 13:892\u2013900","journal-title":"Autoimmun Rev"},{"key":"1466_CR11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00403-011-1134-z","volume":"303","author":"D Rigante","year":"2011","unstructured":"Rigante D, Cantarini L (2011) Monogenic autoinflammatory syndromes at a dermatological level. Arch Dermatol Res 303:375\u2013380","journal-title":"Arch Dermatol Res"},{"key":"1466_CR12","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S1297-319X(02)00452-9","volume":"69","author":"M Younes","year":"2002","unstructured":"Younes M, Kahn MF, Meyer O (2002) Hip involvement in patients with familial Mediterranean fever. A review of ten cases. Joint Bone Spine 69:560\u2013565","journal-title":"Joint Bone Spine"},{"key":"1466_CR13","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/RHU.0b013e31823682f5","volume":"17","author":"SA Bilgen","year":"2011","unstructured":"Bilgen SA, Kilic L, Akdogan A, Kiraz S, Kalyoncu U, Karadag O et al (2011) Effects of anti-tumor necrosis factor agents for familial Mediterranean fever patients with chronic arthritis and\/or sacroiliitis who were resistant to colchicine treatment. J Clin Rheumatol 17:358\u2013362","journal-title":"J Clin Rheumatol"},{"key":"1466_CR14","first-page":"41","volume":"14","author":"K Okutur","year":"2008","unstructured":"Okutur K, Seber S, Oztekin E, Bes C, Borlu F (2008) Recurrent pericarditis as the initial manifestation of Familial Mediterranean fever. Med Sci Monit 14:41","journal-title":"Med Sci Monit"},{"key":"1466_CR15","first-page":"68","volume":"40","author":"F Salehzadeh","year":"2015","unstructured":"Salehzadeh F, Asl MJ, Asl SH, Jahangiri S, Habibzadeh S (2015) MEFV gene profile in Northwest of Iran, twelve common MEFV gene mutations analysis in 216 patients with familial Mediterranean fever. Iran J Med Sci 40:68\u201372","journal-title":"Iran J Med Sci"},{"key":"1466_CR16","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/rheumatology\/ken509","volume":"48","author":"F Yal\u00e7inkaya","year":"2009","unstructured":"Yal\u00e7inkaya F, Ozen S, Oz\u00e7akar ZB, Aktay N, Cakar N, D\u00fczova A et al (2009) A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. Rheumatology 48:395\u2013398","journal-title":"Rheumatology"},{"key":"1466_CR17","first-page":"173","volume":"10","author":"D Rigante","year":"2006","unstructured":"Rigante D, La Torraca I, Avallone L, Pugliese AL, Gaspari S, Stabile A (2006) The pharmacologic basis of treatment with colchicine in children with familial Mediterranean fever. Eur Rev Med Pharmacol Sci 10:173\u2013178","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1466_CR18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.semarthrit.2010.11.003","volume":"41","author":"U Meinzer","year":"2011","unstructured":"Meinzer U, Quartier P, Alexandra JF, Hentgen V, Retornaz F, Kon\u00e9-Paut I (2011) Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature. Semin Arthritis Rheum 41:265\u2013271","journal-title":"Semin Arthritis Rheum"},{"key":"1466_CR19","doi-asserted-by":"crossref","first-page":"939847","DOI":"10.1155\/2013\/939847","volume":"2013","author":"A Vitale","year":"2013","unstructured":"Vitale A, Rigante D, Lucherini OM, Caso F, Muscari I, Magnotti F et al (2013) Biological treatments: new weapons in the management of monogenic autoinflammatory disorders. Mediat Inflamm 2013:939847","journal-title":"Mediat Inflamm"},{"key":"1466_CR20","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/rheumatology\/kep140","volume":"48","author":"E Lainka","year":"2009","unstructured":"Lainka E, Neudorf U, Lohse P, Timmann C, Stojanov S, Huss K et al (2009) Incidence of TNFRSF1A mutations in German children: epidemiological, clinical and genetic characteristics. Rheumatol Oxf 48:987\u2013991","journal-title":"Rheumatol Oxf"},{"key":"1466_CR21","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1136\/annrheumdis-2011-201197","volume":"71","author":"LJ Dickie","year":"2012","unstructured":"Dickie LJ, Aziz AM, Savic S, Lucherini OM, Cantarini L, Geiler J et al (2012) Involvement of X-box binding protein 1 and reactive oxygen species pathways in the pathogenesis of tumour necrosis factor receptor-associated periodic syndrome. Ann Rheum Dis 71:2035\u20132043","journal-title":"Ann Rheum Dis"},{"key":"1466_CR22","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s10067-014-2722-z","volume":"33","author":"D Rigante","year":"2014","unstructured":"Rigante D, Lopalco G, Vitale A, Lucherini OM, De Clemente C, Caso F et al (2014) Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome. Clin Rheumatol 33:1197\u20131207","journal-title":"Clin Rheumatol"},{"key":"1466_CR23","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1084\/jem.20102049","volume":"208","author":"AC Bulua","year":"2011","unstructured":"Bulua AC, Simon A, Maddipati R, Pelletier M, Park H, Kim KY et al (2011) Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS). Exp Med 208:519\u2013533","journal-title":"Exp Med"},{"key":"1466_CR24","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1136\/ard.2005.048611","volume":"65","author":"N Ravet","year":"2006","unstructured":"Ravet N, Rouaghe S, Dod\u00e9 C, Bienvenu J, Stirnemann J, L\u00e9vy P et al (2006) Clinical significance of P46L and R92Q substitutions in the tumour necrosis factor superfamily 1A gene. Ann Rheum Dis 65:1158\u20131162","journal-title":"Ann Rheum Dis"},{"key":"1466_CR25","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1007\/s00296-010-1512-4","volume":"32","author":"L Cantarini","year":"2012","unstructured":"Cantarini L, Lucherini OM, Cimaz R, Rigante D, Baldari CT, Laghi Pasini F et al (2012) Typical and severe tumor necrosis factor receptor-associated periodic syndrome in the absence of mutations in the TNFRSF1A gene: a case series. Rheumatol Int 32:4015\u20134018","journal-title":"Rheumatol Int"},{"key":"1466_CR26","doi-asserted-by":"crossref","first-page":"e73443","DOI":"10.1371\/journal.pone.0073443","volume":"8","author":"OM Lucherini","year":"2013","unstructured":"Lucherini OM, Obici L, Ferracin M, Fulci V, McDermott MF, Merlini G et al (2013) First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS). PLoS One 8:e73443","journal-title":"PLoS One"},{"key":"1466_CR27","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1002\/art.10448","volume":"46","author":"KM Hull","year":"2002","unstructured":"Hull KM, Wong K, Wood GM, Chu WS, Kastner DL (2002) Monocytic fasciitis: a newly recognized clinical feature of tumor necrosis factor receptor dysfunction. Arthritis Rheum 46:2189\u20132194","journal-title":"Arthritis Rheum"},{"key":"1466_CR28","doi-asserted-by":"crossref","first-page":"20405","DOI":"10.5070\/D31911020405","volume":"19","author":"M Cattalini","year":"2013","unstructured":"Cattalini M, Meini A, Monari P, Gualdi G, Arisi M, Pelucchi F et al (2013) Recurrent migratory angioedema as cutaneous manifestation in a familiar case of TRAPS: dramatic response to anakinra. Dermatol Online J 19:20405","journal-title":"Dermatol Online J"},{"key":"1466_CR29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1086\/321976","volume":"69","author":"I Aksentijevich","year":"2001","unstructured":"Aksentijevich I, Galon J, Soares M, Mansfield E, Hull K, Oh HH et al (2001) The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. Am J Hum Genet 69:301\u2013314","journal-title":"Am J Hum Genet"},{"key":"1466_CR30","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1002\/art.10429","volume":"46","author":"C Dod\u00e9","year":"2002","unstructured":"Dod\u00e9 C, Andr\u00e9 M, Bienvenu T, Hausfater P, P\u00e9cheux C, Bienvenu J et al (2002) The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum 46:2181\u20132188","journal-title":"Arthritis Rheum"},{"key":"1466_CR31","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.autrev.2012.07.023","volume":"12","author":"S Maestroni","year":"2012","unstructured":"Maestroni S, Di Corato PR, Cumetti D, Chiara DB, Ghidoni S, Prisacaru L et al (2012) Recurrent pericarditis: autoimmune or autoinflammatory? Autoimmun Rev 12:60\u201365","journal-title":"Autoimmun Rev"},{"key":"1466_CR32","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1002\/art.10509","volume":"46","author":"E Aganna","year":"2002","unstructured":"Aganna E, Martinon F, Hawkins PN, Ross JB, Swan DC, Booth DR et al (2002) Association of mutations in the NALP3\/CIAS1\/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. Arthritis Rheum 46:2445\u20132452","journal-title":"Arthritis Rheum"},{"key":"1466_CR33","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1136\/annrheumdis-2013-204184","volume":"73","author":"HJ Lachmann","year":"2014","unstructured":"Lachmann HJ, Papa R, Gerhold K, Obici L, Touitou I, Cantarini L et al (2014) Paediatric Rheumatology International Trials Organisation (PRINTO), the EUROTRAPS and the Eurofever Project. The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever\/EUROTRAPS international registry. Ann Rheum Dis 73:2160\u20132167","journal-title":"Ann Rheum Dis"},{"key":"1466_CR34","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/imj.12163","volume":"43","author":"L Cantarini","year":"2013","unstructured":"Cantarini L, Lucherini OM, Vitale A, Sabadini L, Brizi MG, Frediani B et al (2013) Expanding spectrum of TNFRSF1A gene mutations among patients with idiopathic recurrent acute pericarditis. Intern Med J 43:725\u2013727","journal-title":"Intern Med J"},{"key":"1466_CR35","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0092-8674(00)80721-7","volume":"97","author":"MF McDermott","year":"1999","unstructured":"McDermott MF, Aksentijevich I, Galon J, McDermott EM, Ogunkolade BW, Centola M et al (1999) Germline mutations in the extracellular domains of the 55\u00a0kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 97:133\u2013144","journal-title":"Cell"},{"key":"1466_CR36","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00392-012-0422-8","volume":"101","author":"L Cantarini","year":"2012","unstructured":"Cantarini L, Lucherini OM, Brucato A, Barone L, Cumetti D, Iacoponi F (2012) Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study. Clin Res Cardiol 101:525\u2013531","journal-title":"Clin Res Cardiol"},{"key":"1466_CR37","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1136\/ard.2007.079376","volume":"67","author":"S Stojanov","year":"2008","unstructured":"Stojanov S, Dejaco C, Lohse P, Huss K, Duftner C, Belohradsky BH et al (2008) Clinical and functional characterization of a novel TNFRSF1A c.605T\u00a0>\u00a0A\/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment. Ann Rheum Dis 67:1292\u20131298","journal-title":"Ann Rheum Dis"},{"key":"1466_CR38","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3109\/07853890.2010.547212","volume":"43","author":"D Rigante","year":"2011","unstructured":"Rigante D, Cantarini L, Imazio M, Lucherini OM, Sacco E, Galeazzi M et al (2011) Autoinflammatory diseases and cardiovascular manifestations. Ann Med 43:341\u2013346","journal-title":"Ann Med"},{"key":"1466_CR39","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/art.33416","volume":"64","author":"AC Bulua","year":"2012","unstructured":"Bulua AC, Mogul DB, Aksentijevich I, Singh H, He DY, Muenza LR et al (2012) Efficacy of etanercept in the tumor necrosis factor receptor-associated periodic syndrome: a prospective, open-label, dose-escalation study. Arthritis Rheum 64:908\u2013913","journal-title":"Arthritis Rheum"},{"key":"1466_CR40","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1136\/ard.2010.143438","volume":"70","author":"L Obici","year":"2011","unstructured":"Obici L, Meini A, Cattalini M, Chicca S, Galliani M, Donadei S et al (2011) Favourable and sustained response to anakinra in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) with or without AA amyloidosis. Ann Rheum Dis 70:1511\u20131512","journal-title":"Ann Rheum Dis"},{"key":"1466_CR41","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1136\/ard.2010.144279","volume":"70","author":"N Quillinan","year":"2011","unstructured":"Quillinan N, Mannion G, Mohammad A, Coughlan R, Dickie LJ, McDermott MF et al (2011) Failure of sustained response to etanercept and refractoriness to anakinra in patients with T50\u00a0M TNF-receptor associated periodic syndrome. Ann Rheum Dis 70:1692\u20131693","journal-title":"Ann Rheum Dis"},{"key":"1466_CR42","doi-asserted-by":"crossref","first-page":"907","DOI":"10.7326\/0003-4819-156-12-201206190-00027","volume":"156","author":"MG Brizi","year":"2012","unstructured":"Brizi MG, Galeazzi M, Lucherini OM, Cantarini L, Cimaz R (2012) Successful treatment of tumor necrosis factor receptor-associated periodic syndrome with canakinumab. Ann Intern Med 156:907\u2013908","journal-title":"Ann Intern Med"},{"issue":"11","key":"1466_CR43","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1007\/s00296-015-3305-2","volume":"35","author":"F Torre La","year":"2015","unstructured":"La Torre F, Muratore M, Vitale A, Moramarco F, Quarta L, Cantarini L (2015) Canakinumab efficacy and long-term tocilizumab administration in tumor necrosis factor receptor-associated periodic syndrome (TRAPS). Rheumatol Int 35(11):1943\u20131947","journal-title":"Rheumatol Int"},{"key":"1466_CR44","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/rheumatology\/keg070","volume":"42","author":"E Drewe","year":"2003","unstructured":"Drewe E, McDermott EM, Powell PT, Isaacs JD, Powell RJ (2003) Prospective study of anti-tumour necrosis factor receptor superfamily 1B fusion protein, and case study of anti-tumour necrosis factor receptor superfamily 1A fusion protein, in tumour necrosis factor receptor associated periodic syndrome (TRAPS): clinical and laboratory findings in a series of seven patients. Rheumatology 42:235\u2013239","journal-title":"Rheumatology"},{"key":"1466_CR45","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00005792-200209000-00002","volume":"81","author":"KM Hull","year":"2002","unstructured":"Hull KM, Drewe E, Aksentijevich I, Singh HK, Wong K, McDermott EM et al (2002) The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Medicine (Baltimore) 81:349\u2013368","journal-title":"Medicine (Baltimore)"},{"key":"1466_CR46","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/art.24294","volume":"60","author":"B Nedjai","year":"2009","unstructured":"Nedjai B, Hitman GA, Quillinan N, Coughlan RJ, Church L, McDermott MF et al (2009) Proinflammatory action of the antiinflammatory drug infliximab in tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum 60:619\u2013625","journal-title":"Arthritis Rheum"},{"key":"1466_CR47","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1146\/annurev-immunol-032414-112227","volume":"33","author":"AA Jesus de","year":"2015","unstructured":"de Jesus AA, Canna SW, Liu Y, Goldbach-Mansky R (2015) Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling. Annu Rev Immunol 33:823\u2013874","journal-title":"Annu Rev Immunol"},{"key":"1466_CR48","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1177\/039463201102400402","volume":"24","author":"L Cantarini","year":"2011","unstructured":"Cantarini L, Lucherini OM, Frediani B, Brizi MG, Bartolomei B, Cimaz R et al (2011) Bridging the gap between the clinician and the patient with cryopyrin-associated periodic syndromes. Int J Immunopathol Pharmacol 24:827\u2013836","journal-title":"Int J Immunopathol Pharmacol"},{"key":"1466_CR49","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00726-008-0097-7","volume":"36","author":"J Pietzsch","year":"2009","unstructured":"Pietzsch J, Hoppmann S (2009) Human S100A12: a novel key player in inflammation? Amino Acids 36:381\u2013389","journal-title":"Amino Acids"},{"key":"1466_CR50","doi-asserted-by":"crossref","first-page":"907078","DOI":"10.1155\/2012\/907078","volume":"2012","author":"B Meijer","year":"2012","unstructured":"Meijer B, Gearry RB, Day AS (2012) The role of S100A12 as a systemic marker of inflammation. Int J Inflam 2012:907078","journal-title":"Int J Inflam"},{"key":"1466_CR51","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJMoa055137","volume":"355","author":"R Goldbach-Mansky","year":"2006","unstructured":"Goldbach-Mansky R, Dailey NJ, Canna SW, Gelabert A, Jones J, Rubin BI et al (2006) Neonatal-onset multisystem inflammatory disease responsive to interleukin-1\u03b2 inhibition. N Engl J Med 355:581\u2013592","journal-title":"N Engl J Med"},{"issue":"11","key":"1466_CR52","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1136\/annrheumdis-2013-204991","volume":"74","author":"R Levy","year":"2014","unstructured":"Levy R, G\u00e9rard L, Kuemmerle-Descher J, Lachmann HJ, Kon\u00e8-Paut I, Cantarini L et al (2014) Phenotipic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever registry. Ann Rheum Dis 74(11):2043\u20132049","journal-title":"Ann Rheum Dis"},{"key":"1466_CR53","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1182\/blood-2003-07-2531","volume":"103","author":"B Neven","year":"2004","unstructured":"Neven B, Callebaut I, Prieur AM, Feldmann J, Bodemer C, Lepore L et al (2004) Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA\/NOMID, MWS, and FCU. Blood 103:2809\u20132815","journal-title":"Blood"},{"key":"1466_CR54","first-page":"943","volume":"30","author":"A Vitale","year":"2012","unstructured":"Vitale A, Lucherini OM, Galeazzi M, Frediani B, Cantarini L (2012) Long-term clinical course of patients carrying the Q703\u00a0K mutation in the NLRP3 gene: a case series. Clin Exp Rheumatol 30:943\u2013946","journal-title":"Clin Exp Rheumatol"},{"issue":"3 Suppl 77","key":"1466_CR55","first-page":"155","volume":"31","author":"A Vitale","year":"2013","unstructured":"Vitale A, Rigante D, Maggio MC, Emmi G, Romano M, Silvestri E et al (2013) Rare NLRP12 variants associated with the NLRP12-autoinflammatory disorder phenotype: an Italian case series. Clin Exp Rheumatol 31(3 Suppl 77):155\u2013156","journal-title":"Clin Exp Rheumatol"},{"key":"1466_CR56","first-page":"994","volume":"32","author":"A Vitale","year":"2014","unstructured":"Vitale A, Rigante D, Lucherini OM, Caso F, Cantarini L (2014) The role of the F402L allele in the NLRP12-autoinflammatory disorder. Reply to: F402L variant in NLRP12 in subjects with undiagnosed periodic fevers and in healthy controls, De Pieri et al. Clin Exp Rheumatol 32:994","journal-title":"Clin Exp Rheumatol"},{"key":"1466_CR57","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/03009740310003974","volume":"32","author":"G Federico","year":"2003","unstructured":"Federico G, Rigante D, Al Pugliese, Ranno O, Catania S, Stabile A (2003) Etanercept induces improvement of arthropathy in chronic infantile neurological cutaneous articular (CINCA) syndrome. Scand J Rheumatol 32:312\u2013314","journal-title":"Scand J Rheumatol"},{"key":"1466_CR58","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00381-006-1280-3","volume":"22","author":"D Rigante","year":"2006","unstructured":"Rigante D, Ansuini V, Caldarelli M, Bertoni B, La Torraca I, Stabile A (2006) Hydrocephalus in CINCA syndrome treated with anakinra. Childs Nerv Syst 22:334\u2013337","journal-title":"Childs Nerv Syst"},{"key":"1466_CR59","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/j.clinthera.2012.09.009","volume":"34","author":"HM Hoffman","year":"2012","unstructured":"Hoffman HM, Throne ML, Amar NJ, Cartwright RC, Kivitz AJ, Soo Y et al (2012) Long-term efficacy and safety profile of rilonacept in the treatment of cryopryin-associated periodic syndromes: results of a 72-week open-label extension study. Clin Ther 34:2091\u20132103","journal-title":"Clin Ther"},{"key":"1466_CR60","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1002\/art.23620","volume":"58","author":"R Goldbach-Mansky","year":"2008","unstructured":"Goldbach-Mansky R, Shroff SD, Wilson M, Snyder C, Plehn S, Barham B et al (2008) A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 Trap) in patients with familial cold autoinflammatory syndrome. Arthritis Rheum 58:2432\u20132442","journal-title":"Arthritis Rheum"},{"key":"1466_CR61","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa0810787","volume":"360","author":"HJ Lachmann","year":"2009","unstructured":"Lachmann HJ, Kone-Paut I, Kuemmerle-Deschner JB, Leslie KS, Hachulla E, Quartier P et al (2009) Use of canakinumab in the cryopyrin-associated periodic syndrome. N Engl J Med 360:2416\u20132425","journal-title":"N Engl J Med"},{"key":"1466_CR62","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1002\/art.22194","volume":"54","author":"SH Mendey","year":"2006","unstructured":"Mendey SH, Kuijk LM, Frenkel J (2006) A role for geranylgeranylation in interleukin-1\u03b2 secretion. Arthritis Rheum 54:3690\u20133695","journal-title":"Arthritis Rheum"},{"key":"1466_CR63","doi-asserted-by":"crossref","first-page":"e535","DOI":"10.1542\/peds.2010-2192","volume":"129","author":"A Ruiz Gomez","year":"2012","unstructured":"Ruiz Gomez A, Couce ML, Garcia-Villoria J, Torres A, Bana Souto A, Yague J et al (2012) Clinical, genetic, and therapeutic diversity in 2 patients with severe mevalonate kinase deficiency. Pediatrics 129:e535\u2013e539","journal-title":"Pediatrics"},{"key":"1466_CR64","doi-asserted-by":"crossref","first-page":"R86","DOI":"10.1152\/ajpregu.00504.2006","volume":"292","author":"A Simon","year":"2007","unstructured":"Simon A, van der Meer JW (2007) Pathogenesis of familial periodic fever syndromes or hereditary autoinflammatory syndromes. Am J Physiol Regul Integr Comp Physiol 292:R86\u2013R98","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"1466_CR65","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/sj.ejhg.5200614","volume":"9","author":"L Cuisset","year":"2001","unstructured":"Cuisset L, Drenth JP, Simon A, Vincent MF, van der Velde Visser S, van der Meer JW et al (2001) Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome. Eur J Hum Genet 9:260\u2013266","journal-title":"Eur J Hum Genet"},{"key":"1466_CR66","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/MD.0b013e318190cfb7","volume":"87","author":"JC Hilst van der","year":"2008","unstructured":"van der Hilst JC, Bodar EJ, Barron KS, Frenkel J, Drenth JP, van der Meer JW et al (2008) Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine 87:301\u2013310","journal-title":"Medicine"},{"key":"1466_CR67","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1542\/peds.2010-3639","volume":"128","author":"B Bader-Meunier","year":"2011","unstructured":"Bader-Meunier B, Florkin B, Sibilia J, Acquaviva C, Hachulla E, Grateau G et al (2011) Mevalonate kinase deficiency: a survey of 50 patients. Pediatrics 128:e152\u2013e159","journal-title":"Pediatrics"},{"key":"1466_CR68","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/archderm.1994.01690010063008","volume":"130","author":"JP Drenth","year":"1994","unstructured":"Drenth JP, Boom BW, Toonstra J, van der Meer JW (1994) Cutaneous manifestations and histologic findings in the hyperimmunoglobulinemia D syndrome. International Hyper-IgD Study Group. Arch Dermatol 130:59\u201365","journal-title":"Arch Dermatol"},{"key":"1466_CR69","first-page":"53","volume":"10","author":"A Stabile","year":"2006","unstructured":"Stabile A, Bertoni B, Ansuini V, La Torraca I, Sall\u00ec A, Rigante D (2006) The clinical spectrum and treatment options of macrophage activation syndrome in the pediatric age. Eur Rev Med Pharmacol Sci 10:53\u201359","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1466_CR70","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s10067-015-2923-0","volume":"34","author":"D Rigante","year":"2015","unstructured":"Rigante D, Emmi G, Fastiggi M, Silvestri E, Cantarini L (2015) Macrophage activation syndrome in the course of monogenic autoinflammatory disorders. Clin Rheumatol 34:1333\u20131339","journal-title":"Clin Rheumatol"},{"key":"1466_CR71","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/art.11218","volume":"48","author":"K Takada","year":"2003","unstructured":"Takada K, Aksentijevich I, Mahadevan V, Dean JA, Kelley RI, Kastner DL (2003) Favorable preliminary experience with etanercept in two patients with the hyperimmunoglobulinemia D and periodic fever syndrome. Arthritis Rheum 48:2645\u20132651","journal-title":"Arthritis Rheum"},{"key":"1466_CR72","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1093\/rheumatology\/kes097","volume":"51","author":"C Galeotti","year":"2012","unstructured":"Galeotti C, Meinzer U, Quartier P, Rossi-Semerano L, Bader-Meunier B, Pillet P et al (2012) Efficacy of interleukin-1-targeting drugs in mevalonate kinase deficiency. Rheumatol Oxf 51:1855\u20131859","journal-title":"Rheumatol Oxf"},{"key":"1466_CR73","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1136\/annrheumdis-2011-201268","volume":"72","author":"N Haar ter","year":"2013","unstructured":"ter Haar N, Lachmann H, Ozen S, Woo P, Uziel Y, Modesto C et al (2013) Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review. Ann Rheum Dis 72:678\u2013685","journal-title":"Ann Rheum Dis"},{"key":"1466_CR74","first-page":"269","volume":"30","author":"L Cantarini","year":"2012","unstructured":"Cantarini L, Vitale A, Bartolomei B, Galeazzi M, Rigante D (2012) Diagnosis of PFAPA syndrome applied to a cohort of 17 adults with unexplained recurrent fevers. Clin Exp Rheumatol 30:269\u2013271","journal-title":"Clin Exp Rheumatol"},{"key":"1466_CR75","first-page":"358","volume":"10","author":"S Padeh","year":"2008","unstructured":"Padeh S, Stoffman N, Berkun Y (2008) Periodic fever accompanied by aphthous stomatitis, pharyngitis and cervical adenitis syndrome (PFAPA syndrome) in adults. Isr Med Assoc J 10:358\u2013360","journal-title":"Isr Med Assoc J"},{"key":"1466_CR76","doi-asserted-by":"crossref","first-page":"298","DOI":"10.12659\/MSM.892289","volume":"21","author":"S Ozen","year":"2015","unstructured":"Ozen S, Y\u0131lmaz R, S\u00f6nmezg\u00f6z E, Karaaslan E, Ta\u015fk\u0131n S, B\u00fct\u00fcn \u0130 et al (2015) Simple markers for subclinical inflammation in patients with familial Mediterranean fever. Med Sci Monit 21:298\u2013303","journal-title":"Med Sci Monit"},{"key":"1466_CR77","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/art.37827","volume":"65","author":"T Lane","year":"2013","unstructured":"Lane T, Loeffler JM, Rowczenio DM, Gilbertson JA, Bybee A, Russell TL et al (2013) AA amyloidosis complicating the hereditary periodic fever syndromes. Arthritis Rheum 65:1116\u20131121","journal-title":"Arthritis Rheum"},{"key":"1466_CR78","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/art.23474","volume":"58","author":"M Gattorno","year":"2008","unstructured":"Gattorno M, Sormani MP, D\u2019Osualdo A, Pelagatti MA, Caroli F, Federici S et al (2008) A diagnostic score for molecular analysis of hereditary autoinflammatory syndromes with periodic fever in children. Arthritis Rheum 58:1823\u20131832","journal-title":"Arthritis Rheum"},{"key":"1466_CR79","doi-asserted-by":"crossref","first-page":"485103","DOI":"10.1155\/2013\/485103","volume":"2013","author":"D Rigante","year":"2013","unstructured":"Rigante D, Frediani B, Galeazzi M, Cantarini L (2013) From the Mediterranean to the sea of Japan: the transcontinental odyssey of autoinflammatory diseases. Biomed Res Int 2013:485103","journal-title":"Biomed Res Int"},{"key":"1466_CR80","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1177\/039463201102400315","volume":"24","author":"L Cantarini","year":"2011","unstructured":"Cantarini L, Iacoponi F, Lucherini OM, Obici L, Brizi MG, Cimaz R et al (2011) Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults. Int J Immunopathol Pharmacol 24:695\u2013702","journal-title":"Int J Immunopathol Pharmacol"},{"key":"1466_CR81","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1177\/039463201002300417","volume":"23","author":"L Cantarini","year":"2010","unstructured":"Cantarini L, Lucherini OM, Iacoponi F, Cimaz R, Simonini G, Rigante D et al (2010) Development and preliminary validation of a diagnostic score for identifying patients affected with adult-onset autoinflammatory disorders. Int J Immunopathol Pharmacol 23:1133\u20131141","journal-title":"Int J Immunopathol Pharmacol"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-016-1466-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11739-016-1466-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-016-1466-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T10:56:47Z","timestamp":1656586607000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11739-016-1466-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,25]]},"references-count":81,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["1466"],"URL":"https:\/\/doi.org\/10.1007\/s11739-016-1466-y","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,25]]}}}